Rotella Capital Management’s PDL BioPharma, Inc. PDLI Stock Holding History

Rotella Capital Management’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-111,491	Closed	-$395K	–	386
2015 Q4	$395K	Sell	111,491 -172,263	-61%	-$721K	0.35%	142
2015 Q3	$1.43M	Buy	283,754 +254,454	+868%	+$1.46M	0.46%	21
2015 Q2	$188K	Sell	29,300 -6,700	-19%	-$44.9K	0.15%	181
2015 Q1	$253K	Buy	36,000 +4,300	+14%	+$31.1K	0.21%	139
2014 Q4	$244K	Buy	31,700 +15,000	+90%	+$119K	0.21%	104
2014 Q3	$125K	Sell	16,700 -5,500	-25%	-$51.1K	0.13%	151
2014 Q2	$215K	Buy	+22,200	New	+$198K	0.18%	107

Other funds holding PDLI

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

GAM

Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Rotella Capital Management's PDLI Position: Q1 2016 in Review

Rotella Capital Management sold out of PDL BioPharma, Inc. (PDLI) in Q1 2016, closing a stake of 111,491 shares — an estimated $395K sold.

Rotella Capital Management first reported a position in PDLI in Q2 2014 and held it in 7 quarters. The position peaked at $1.43M in Q3 2015. 195 funds tracked by Wall St. Rank hold PDLI as of Q1 2016.

Rotella Capital Management reported no remaining PDL BioPharma, Inc. position as of Q1 2016 after selling out during the quarter.
Rotella Capital Management sold 111,491 PDL BioPharma, Inc. shares in Q1 2016, an estimated $395K.
Rotella Capital Management first reported a position in PDL BioPharma, Inc. in Q2 2014 and held it in 7 quarters.
Rotella Capital Management's PDL BioPharma, Inc. position peaked at $1.43M in Q3 2015.
195 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q1 2016.

Based on Rotella Capital Management's 13F filing for Q1 2016, filed 13 May 2016.